Clinical trial
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
NCT01221870
Study timeline
Study start (unknown)2010-11-01Date precision: month
Registry last updated2012-07-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Neoplasmunresolved
Interventions
Sponsors & collaborators
Genta Incorporatedlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01221870 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.